ArticleAnnals of surgical oncology2026

High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell Carcinoma.

Kosaku Torii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.